olomoucine and Atherosclerotic Parkinsonism

olomoucine has been researched along with Atherosclerotic Parkinsonism in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Fei, XF; Fukunaga, K; Han, F; Li, LY; Liang, ZQ; Qin, ZH; Xiang, B	1

Other Studies

1 other study(ies) available for olomoucine and Atherosclerotic Parkinsonism

Article	Year
Olomoucine inhibits cathepsin L nuclear translocation, activates autophagy and attenuates toxicity of 6-hydroxydopamine. Brain research, 2009, Apr-06, Volume: 1264 Topics: Analysis of Variance; Animals; Autophagy; Cathepsin L; Cathepsins; Cell Count; Cell Cycle; Cell Death; Cells, Cultured; Cyclin B; Cyclin D1; Cysteine Endopeptidases; Enzyme Inhibitors; Fluorescent Antibody Technique; Kinetin; Male; Microtubule-Associated Proteins; Neurons; Oxidopamine; Parkinson Disease, Secondary; Proliferating Cell Nuclear Antigen; Protein Transport; Rats; Rats, Sprague-Dawley; Reverse Transcriptase Polymerase Chain Reaction; Substantia Nigra; Time Factors; Tyrosine 3-Monooxygenase; Up-Regulation	2009

Article

Year

Olomoucine inhibits cathepsin L nuclear translocation, activates autophagy and attenuates toxicity of 6-hydroxydopamine.

Brain research, 2009, Apr-06, Volume: 1264

Topics: Analysis of Variance; Animals; Autophagy; Cathepsin L; Cathepsins; Cell Count; Cell Cycle; Cell Death; Cells, Cultured; Cyclin B; Cyclin D1; Cysteine Endopeptidases; Enzyme Inhibitors; Fluorescent Antibody Technique; Kinetin; Male; Microtubule-Associated Proteins; Neurons; Oxidopamine; Parkinson Disease, Secondary; Proliferating Cell Nuclear Antigen; Protein Transport; Rats; Rats, Sprague-Dawley; Reverse Transcriptase Polymerase Chain Reaction; Substantia Nigra; Time Factors; Tyrosine 3-Monooxygenase; Up-Regulation

2009